Kempharm Stock Shares Outstanding
| KMPHDelisted Stock | USD 5.81 0.02 0.34% |
KemPharm fundamentals help investors to digest information that contributes to KemPharm's financial success or failures. It also enables traders to predict the movement of KemPharm Stock. The fundamental analysis module provides a way to measure KemPharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to KemPharm stock.
KemPharm |
KemPharm Company Shares Outstanding Analysis
KemPharm's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current KemPharm Shares Outstanding | 34.5 M |
Most of KemPharm's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, KemPharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, KemPharm has 34.5 M of shares currently outstending. This is 80.89% lower than that of the Pharmaceuticals sector and 67.71% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 93.97% higher than that of the company.
KemPharm Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses KemPharm's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of KemPharm could also be used in its relative valuation, which is a method of valuing KemPharm by comparing valuation metrics of similar companies.KemPharm is currently under evaluation in shares outstanding category among related companies.
KemPharm Fundamentals
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0897 | |||
| Operating Margin | (1.72) % | |||
| Current Valuation | 97.06 M | |||
| Shares Outstanding | 34.5 M | |||
| Shares Owned By Insiders | 10.29 % | |||
| Shares Owned By Institutions | 17.68 % | |||
| Number Of Shares Shorted | 1.37 M | |||
| Price To Earning | 17.87 X | |||
| Price To Book | 1.69 X | |||
| Price To Sales | 14.16 X | |||
| Revenue | 28.65 M | |||
| Gross Profit | 26.59 M | |||
| EBITDA | (8.29 M) | |||
| Net Income | (8.55 M) | |||
| Cash And Equivalents | 80.98 M | |||
| Cash Per Share | 2.35 X | |||
| Total Debt | 16.16 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 12.21 X | |||
| Book Value Per Share | 2.72 X | |||
| Cash Flow From Operations | 10.44 M | |||
| Short Ratio | 5.87 X | |||
| Earnings Per Share | (0.91) X | |||
| Target Price | 22.33 | |||
| Number Of Employees | 24 | |||
| Beta | 2.16 | |||
| Market Capitalization | 200.65 M | |||
| Total Asset | 132.94 M | |||
| Retained Earnings | (252.18 M) | |||
| Working Capital | 45.74 M | |||
| Current Asset | 54.08 M | |||
| Current Liabilities | 8.34 M | |||
| Z Score | 5.8 | |||
| Net Asset | 132.94 M |
About KemPharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze KemPharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KemPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KemPharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in KemPharm Stock
If you are still planning to invest in KemPharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KemPharm's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |